References
- Aminisani, N., Nikbakht, H., Asghari Jafarabadi, M., & Shamshirgaran, S. M. (2017). Depression, anxiety, and health related quality of life among colorectal cancer survivors. Journal of Gastrointestinal Oncology, 8(1), 81–88.
- Arrieta, O., Angulo, L. P., Nunez-Valencia, C., Dorantes-Gallareta, Y., Macedo, E. O., & Martinez-Lopez, D. (2013). Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Annals of Surgical Oncology, 20(6), 1941–1948.
- Caruso, R., Nanni, M. G., Riba, M., Sabato, S., Mitchell, A. J., & Croce, E. (2017). Depressive spectrum disorders in cancer: Prevalence, risk factors and screening for depression: A critical review. Acta Oncologica (Stockholm, Sweden), 56(2), 146–155.
- Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., & Bray, F. (2016). Cancer statistics in China, 2015. CA: a Cancer Journal for Clinicians, 66(2), 115–132.
- Curran, L., Sharpe, L., & Butow, P. (2017). Anxiety in the context of cancer: A systematic review and development of an integrated model. Clinical Psychology Review, 56, 40–54.
- Dang, Y., Shi, X., Xu, W., & Zuo, M. (2018). The effect of anesthesia on the immune system in colorectal cancer patients. Canadian Journal of Gastroenterology and Hepatology, (2018(p), 7940603.
- Gonzalez-Saenz de Tejada, M., Bilbao, A., Bare, M., Briones, E., Sarasqueta, C., & Quintana, J. M. (2017). Association between social support, functional status, and change in health-related quality of life and changes in anxiety and depression in colorectal cancer patients. Psychooncology, 26(9), 1263–1269.
- Grassi, L., Indelli, M., Marzola, M., Maestri, A., Santini, A., & Piva, E. (1996). Depressive symptoms and quality of life in home-care-assisted cancer patients. Journal of Pain and Symptom Management, 12(5), 300–307.
- Gray, N. M., Hall, S. J., Browne, S., Johnston, M., Lee, A. J., & Macleod, U. (2014). Predictors of anxiety and depression in people with colorectal cancer. Supportive Care in Cancer, 22(2), 307–314.
- Hellstadius, Y., Lagergren, J., Zylstra, J., Gossage, J., Davies, A., & Hultman, C. M. (2016). Prevalence and predictors of anxiety and depression among esophageal cancer patients prior to surgery. Diseases of the Esophagus, 29(8), 1128–1134.
- Inamura, K. (2018). Colorectal cancers: An update on their molecular pathology. Cancers, 10(1), 26.
- Mols, F., Schoormans, D., de Hingh, I., Oerlemans, S., & Husson, O. (2018). Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: Prevalence, predictors, and impact on quality of life. Cancer, 124(12), 2621–2628.
- Polat, U., Arpaci, A., Demir, S., Erdal, S., & Yalcin, S. (2014). Evaluation of quality of life and anxiety and depression levels in patients receiving chemotherapy for colorectal cancer: Impact of patient education before treatment initiation. Journal of Gastrointestinal Oncology, 5(4), 270–275.
- Schag, C. A., & Heinrich, R. L. (1989). Anxiety in medical situations: Adult cancer patients. Journal of Clinical Psychology, 45(1), 20–27.
- Shin, J. Y., Steger, M. F., Shin, D. W., Kim, S. Y., Yang, H. K., & Cho, J. (2019). Patient-family communication mediates the relation between family hardiness and caregiver positivity: Exploring the moderating role of caregiver depression and anxiety. Journal of Psychosocial Oncology, 1–16.
- Tung, H. Y., Chao, T. B., Lin, Y. H., Wu, S. F., Lee, H. Y., & Ching, C. Y. (2016). Depression, fatigue, and qol in colorectal cancer patients during and after treatment. Western Journal of Nursing Research, 38(7), 893–908.